Pall, a global leader in filtration, separation and purification, completed the acquisition of Single Use Support, a provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill finish. Financial terms were not disclosed. "Safe and reliable management of drug substances is a challenge for many Pall customers. Through our partnership with Single Use Support, Pall will be able to offer the Biopharma industry a fully validated end-to-end solution, which will enable our customers to bring life-saving drugs to the patient in a more efficient way," Ed Hoare, Pall Vice President and General Manager.